11/01/2024 3:30 PM | TNF Pharmaceuticals, Inc. (Filer) TNF Pharmaceuticals, Inc. (Filer) TNF Pharmaceuticals (Filer)
| Form DEF 14A | |
11/01/2024 3:31 PM | TNF Pharmaceuticals, Inc. (Filer) TNF Pharmaceuticals, Inc. (Filer) TNF Pharmaceuticals (Filer)
| Form ARS | |
10/04/2024 4:02 PM | TNF Pharmaceuticals, Inc. (Filer) TNF Pharmaceuticals, Inc. (Filer) TNF Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
09/23/2024 3:31 PM | TNF Pharmaceuticals, Inc. (Filer) TNF Pharmaceuticals, Inc. (Filer) TNF Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/19/2024 5:30 AM | TNF Pharmaceuticals, Inc. (Filer) TNF Pharmaceuticals, Inc. (Filer) TNF Pharmaceuticals (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
08/14/2024 3:33 PM | TNF Pharmaceuticals, Inc. (Filer) TNF Pharmaceuticals, Inc. (Filer) TNF Pharmaceuticals (Filer)
| Form NT 10-Q | |
08/12/2024 11:15 PM | TNF Pharmaceuticals, Inc. (Filer) TNF Pharmaceuticals, Inc. (Filer) TNF Pharmaceuticals (Filer)
| Form EFFECT | |
|
08/12/2024 4:10 PM | TNF Pharmaceuticals, Inc. (Filer) TNF Pharmaceuticals, Inc. (Filer) TNF Pharmaceuticals (Filer)
| Form 424B3 | |
08/08/2024 4:13 PM | TNF Pharmaceuticals, Inc. (Filer) TNF Pharmaceuticals, Inc. (Filer) TNF Pharmaceuticals (Filer)
| Form S-3/A | |
07/26/2024 3:30 PM | TNF Pharmaceuticals, Inc. (Filer) TNF Pharmaceuticals, Inc. (Filer) TNF Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
07/01/2024 4:15 PM | MyMD Pharmaceuticals, Inc. (Filer) MyMD Pharmaceuticals, Inc. (Filer) TNF Pharmaceuticals (Filer)
| Form DEF 14A | |
06/24/2024 3:23 PM | MyMD Pharmaceuticals, Inc. (Filer) MyMD Pharmaceuticals, Inc. (Filer) TNF Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/21/2024 4:14 PM | MyMD Pharmaceuticals, Inc. (Filer) MyMD Pharmaceuticals, Inc. (Filer) TNF Pharmaceuticals (Filer)
| Form S-3 Registration statement under Securities Act of 1933 | |
06/20/2024 4:20 PM | MyMD Pharmaceuticals, Inc. (Filer) MyMD Pharmaceuticals, Inc. (Filer) TNF Pharmaceuticals (Filer)
| Form 8-K/A | |
06/17/2024 8:04 AM | MyMD Pharmaceuticals, Inc. (Filer) MyMD Pharmaceuticals, Inc. (Filer) TNF Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/31/2024 7:00 AM | MyMD Pharmaceuticals, Inc. (Filer) MyMD Pharmaceuticals, Inc. (Filer) TNF Pharmaceuticals (Filer)
| Form D Notice of Exempt Offering of Securities | |
05/31/2024 7:00 AM | MyMD Pharmaceuticals, Inc. (Filer) MyMD Pharmaceuticals, Inc. (Filer) TNF Pharmaceuticals (Filer)
| Form D Notice of Exempt Offering of Securities | |
05/21/2024 8:10 AM | MyMD Pharmaceuticals, Inc. (Filer) MyMD Pharmaceuticals, Inc. (Filer) TNF Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/16/2024 4:30 PM | Glass Mitchell (Reporting) MyMD Pharmaceuticals, Inc. (Issuer) MyMD Pharmaceuticals, Inc. (Issuer) TNF Pharmaceuticals (Issuer)
| Form 3 Initial statement of beneficial ownership of securities | |
05/15/2024 4:01 PM | MyMD Pharmaceuticals, Inc. (Filer) MyMD Pharmaceuticals, Inc. (Filer) TNF Pharmaceuticals (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
04/18/2024 3:30 PM | MyMD Pharmaceuticals, Inc. (Filer) MyMD Pharmaceuticals, Inc. (Filer) TNF Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
04/08/2024 3:49 PM | MyMD Pharmaceuticals, Inc. (Filer) MyMD Pharmaceuticals, Inc. (Filer) TNF Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
04/01/2024 4:29 PM | MyMD Pharmaceuticals, Inc. (Filer) MyMD Pharmaceuticals, Inc. (Filer) TNF Pharmaceuticals (Filer)
| Form 10-K Annual report pursuant to Section 13 or 15(d) | |
03/26/2024 3:30 PM | MyMD Pharmaceuticals, Inc. (Filer) MyMD Pharmaceuticals, Inc. (Filer) TNF Pharmaceuticals (Filer)
| Form 8-K/A | |
03/07/2024 3:30 PM | MyMD Pharmaceuticals, Inc. (Filer) MyMD Pharmaceuticals, Inc. (Filer) TNF Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
03/05/2024 10:00 AM | MyMD Pharmaceuticals, Inc. (Filer) MyMD Pharmaceuticals, Inc. (Filer) TNF Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/14/2024 2:13 PM | Global X Management CO LLC (Filed by) MyMD Pharmaceuticals, Inc. (Subject) MyMD Pharmaceuticals, Inc. (Subject) TNF Pharmaceuticals (Subject)
| Form SC 13G | |
02/14/2024 10:27 AM | Iroquois Capital Management, LLC (Filed by) MyMD Pharmaceuticals, Inc. (Subject) MyMD Pharmaceuticals, Inc. (Subject) TNF Pharmaceuticals (Subject)
| Form SC 13G/A | |
12/06/2023 8:15 AM | MyMD Pharmaceuticals, Inc. (Filer) MyMD Pharmaceuticals, Inc. (Filer) TNF Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |